Alkem Laboratories IPO

Alkem Laboratories limited | Initial Public offeringKhaitan & Co advised Alkem Laboratories in relation to its Initial public offer through offer for sale of Equity Shares by Selling Shareholders for approximately $204m. Alkem is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

Sudhir Bassi, Executive Director; Abhimanyu Bhattacharya, Partner; Soumya Mohapatra, Principal Associate; Aanchal Arora, Associate; Aayush Mohata, Associate; Abir Sarkar, Associate and Srikant Mantravedi, Associate represented the client on the trasnsaction